Abstract
These preliminary data suggest that HTx, independent of steroid dosing, is associated with the development of leptin resistance and abdominal obesity and persistence of insulin resistance, states consistent with the metabolic syndrome. This may be secondary to and/or contribute to the dramatic weight gain observed post-HTx.
Original language | English |
---|---|
Pages (from-to) | 516-520 |
Number of pages | 5 |
Journal | European Journal of Heart Failure |
Volume | 12 |
Issue number | 5 |
DOIs | |
State | Published - May 2010 |
Externally published | Yes |